Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



The effect of intravenous administration of ondansetron on analgesia time of caudal block in circumcision cases: A randomized controlled trial

Huseyin Ulas Pinar, Omer Karaca, Isak Akillioglu, Rafi Dogan, Fatma Karakoc.




Abstract

We investigate whether there was any effect of intravenous ondansetron administered for postoperative nausea vomiting prophylaxis on the duration of caudal block action in patients who undergo circumcision surgery. 66 ASA I–II patients aged 4 to 10 and scheduled for circumcision surgery were included in this prospective, randomized controlled study. We administered 0.1 mg/kg ondansetron IV to Group Ondansetron patients before caudal block and same amount of serum physiologic for Group Control patients. After anesthesia induction caudal block with 1 ml/kg 0.25% bupivacaine administered. We evaluated postoperative analgesia durations in each group. There were no difference between groups for number of patients which were painless for first 4 hours and 8 hours, total analgesic requirements for first 24 hours, total time for first analgesic requirements. We concluded that iv ondansetron given at 0.1 mg/kg dose before caudal block with bupivacaine can be used safely without a significant effect on the duration of block-induced analgesia.

Key words: Caudal block, ondansetron, postoperative analgesia






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.